PGNY Q3 2024 Earnings — Progyny, Inc. Revenue & Financial Results | Market Cap Arena

PGNYProgyny, Inc.

$1B

Q3 2024 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$287M+2.0% YoY

Gross Profit

$59M20.7% margin

Operating Income

$12M4.3% margin

Net Income

$10M3.6% margin

EPS (Diluted)

$0.11

QoQ Revenue Growth

-5.7%

Cash Flow

Operating Cash Flow

$45M

Free Cash Flow

$43M

Stock-Based Comp.

$33M

Balance Sheet

Total Assets

$660M

Total Liabilities

$225M

Stockholders' Equity

$435M

Cash & Equivalents

$91M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$287M	$281M	+2.0%
Gross Profit	$59M	$63M	-5.4%
Operating Income	$12M	$18M	-31.5%
Net Income	$10M	$16M	-34.5%

Revenue Segments

Fertility benefit services revenue

$179M62%

Pharmacy benefit services revenue

$108M38%